US Allergy Diagnostics Market (2026-2031)
The US Allergy Diagnostics Market was valued at $1243.9 Million in 2026 and projected to reach to $2025.8 Million by 2031, representing a compound annual growth rate of 10.2%. The US allergy diagnostics market is positioned for sustained growth through 2031, driven by increasing allergy prevalence, healthcare provider adoption of advanced testing platforms, and patient demand for personalized treatment approaches.
US Allergy Diagnostics Market Trends and Insights
- This expansion reflects the US healthcare system's increasing focus on precision diagnostics and personalized medicine for allergic conditions.
- The US market is driven by rising allergy prevalence, advanced diagnostic technologies, and growing patient awareness of allergy testing benefits. In the US, the allergy diagnostics sector benefits from strong healthcare infrastructure, high reimbursement rates, and significant investment in diagnostic innovation.
- The US market's 10.2% compound annual growth rate outpaces global trends, indicating accelerating adoption of both in vitro and in vivo diagnostic methods.
- By 2031, the US is expected to solidify its position as a leading market for allergy diagnostics, supported by regulatory approvals and expanding clinical applications. The US allergy diagnostics landscape encompasses immunoassays, skin prick tests, component-resolved diagnostics, and molecular testing platforms.
- The US market's growth trajectory reflects demographic shifts, environmental factors increasing allergen exposure, and healthcare providers' commitment to evidence-based allergy management strategies..
Key Market Statistics
- CAGR (2026-2031) 10.2% CAGR
- Market Size, 2026 ~USD 1243.9 Million
- Forecast, 2031 ~USD 2025.8 Million
- Country US
US Allergy Diagnostics Market Overview
Market Valuation Growth :
The US allergy diagnostics market is valued at $1,243.9 million in 2026 and is projected to reach $2,025.8 million by 2031, representing a robust 10.2% CAGR over the forecast period.
Rising Allergy Prevalence :
Increasing prevalence of allergic conditions across the US population is driving demand for advanced diagnostic solutions, with more patients seeking accurate identification of allergens.
Precision Medicine Adoption :
The US healthcare system's shift toward precision diagnostics and personalized medicine is accelerating adoption of innovative allergy testing technologies and methodologies.
Advanced Diagnostic Technologies :
Integration of molecular diagnostics, immunoassays, and component-resolved diagnostics in US clinical laboratories is enhancing accuracy and expanding market opportunities.
US Allergy Diagnostics Market Dynamics
- Technological innovations in molecular and component-resolved diagnostics are expanding clinical capabilities and improving diagnostic accuracy across diverse patient populations.
- The US market benefits from strong healthcare infrastructure, reimbursement support, and significant investment in precision medicine initiatives that prioritize early and accurate allergen identification for optimal patient outcomes..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- The US allergy diagnostics market will grow from $1,243.9M (2026) to $2,025.8M (2031) at a 10.2% CAGR, outpacing global growth rates.
- The US market benefits from advanced healthcare infrastructure, strong reimbursement policies, and high diagnostic adoption rates among US healthcare providers.
- Rising allergy prevalence and environmental allergen exposure are key drivers accelerating demand for allergy diagnostics across the US.
- The US market encompasses diverse diagnostic modalities including immunoassays, skin testing, and component-resolved diagnostics, reflecting sophisticated US clinical practices.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
US Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need US market data to develop competitive allergy diagnostic products, understand regulatory pathways, identify distribution channels, and optimize pricing strategies for the American market.
- Healthcare Providers & Laboratories : Clinical laboratories and healthcare systems require market insights to evaluate diagnostic technology investments, benchmark performance against competitors, and align service offerings with patient demand trends.
- Investment & Private Equity Firms : Investors need comprehensive US market analysis to identify acquisition targets, assess growth potential, evaluate market valuations, and make informed capital allocation decisions in the allergy diagnostics sector.
- Pharmaceutical & Biotech Companies : Pharma companies developing allergy treatments need diagnostic market data to understand patient identification pathways, companion diagnostic opportunities, and market segmentation for targeted drug development.
- Healthcare Consultants & Analysts : Consulting firms and research analysts require detailed US market data to support client advisory services, competitive benchmarking, market strategy development, and investment recommendation reports.
Key Companies in the US Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Market Size & Growth Projections : Access detailed valuation data showing the US market growing from $1,243.9M (2026) to $2,025.8M (2031), enabling accurate financial forecasting and investment planning for your organization.
- US-Specific Market Drivers : Understand the unique factors driving US market growth including rising allergy prevalence, precision medicine adoption, and advanced diagnostic technology integration specific to American healthcare systems.
- Competitive Landscape Intelligence : Gain insights into the US competitive environment, key market players, technology trends, and strategic positioning opportunities within the American allergy diagnostics sector.
- Reimbursement & Regulatory Insights : Obtain critical information on US insurance coverage, Medicare/Medicaid reimbursement policies, FDA regulations, and compliance requirements affecting market dynamics and profitability.
- Strategic Market Opportunities : Identify high-growth segments, underserved patient populations, and emerging diagnostic technologies within the US market to guide product development and market entry strategies.
Frequently asked questions
What is the current size of the US allergy diagnostics market?
The US allergy diagnostics market is valued at $1,243.9 million in 2026 and is projected to reach $2,025.8 million by 2031.
What is the expected growth rate for the US allergy diagnostics market?
The US allergy diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 10.2% from 2026 to 2031.
What factors are driving growth in the US allergy diagnostics market?
Key drivers include rising allergy prevalence in the US population, advanced diagnostic technologies, strong healthcare infrastructure, favorable reimbursement policies, and increasing patient awareness of allergy testing benefits.
Which diagnostic methods dominate the US allergy diagnostics market?
The US market includes immunoassays, skin prick tests, component-resolved diagnostics, and molecular testing platforms, with adoption varying by clinical setting and patient population.
How does the US market compare to global allergy diagnostics growth?
The US market's 10.2% CAGR exceeds the global average of 9.6%, reflecting stronger adoption rates and healthcare investment in allergy diagnostics within the US.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report